```markdown
# Formatted Paper Outline

**Format Applied:** APA 7th Edition (adapted for scientific paper structure)
**Target Journal:** Journal of Chemical Information and Modeling
**Word Limit:** 9,000 words (approximate, excluding references and appendices)
**Citation Style:** APA 7th Edition

---

## Formatting Requirements

### Manuscript Specifications
- **Font:** Times New Roman 12pt
- **Line Spacing:** Double
- **Margins:** 1 inch all sides
- **Page Numbers:** Top right, starting on the title page
- **Headings:** Numbered (for clarity in a scientific paper), but follow APA style for appearance.

### Section Heading Levels
- **Level 1:** Bold, Centered, Title Case (e.g., **1. Introduction**)
- **Level 2:** Bold, Left-Aligned, Title Case (e.g., **1.1 Background and Motivation**)
- **Level 3:** Bold, Indented, Sentence case, ending with a period (e.g., **1.1.1. Quantum Simulation Challenges.**)

### Citation Format
- **In-text:** (Author, Year) or Author (Year)
- **Bibliography:** Full APA 7th Edition format specification (see below for details)

### ⚠️ CITATION REQUIREMENTS - CRITICAL

**Specify citation style early and communicate to ALL Crafter agents:**

**Default Style:** APA 7th Edition (unless specified otherwise)

**In-text citation format:**
```
✅ CORRECT: (Author, Year)
✅ CORRECT: (Author & Co-Author, Year)
✅ CORRECT: (Author et al., Year)
❌ WRONG: (Author [VERIFY]) - missing year
```

**Reference list requirements:**
- Use DOI when available: `https://doi.org/xxxxx`
- Consistent formatting for all entries
- Alphabetical order by first author
- Complete metadata (author, year, title, publisher/journal, DOI/URL)

**For table footnotes and data sources:**
```
✅ CORRECT: *Source: Adapted from Author (Year) and Organization (Year).*
❌ WRONG: *Source: Author (Year) [VERIFY].*
```

**[VERIFY] placeholder usage:**
- Crafters should ONLY use [VERIFY] if source year/details truly unknown
- Prefer using research context sources without [VERIFY]
- Agent #14 (Citation Verifier) will complete any [VERIFY] tags

**Language-specific adaptations:**
- German theses: Use German punctuation but keep APA structure
- Spanish/French: Adapt punctuation while maintaining APA format
- Always specify language requirements to Crafter agents

**Communicate to Crafter agents:**
"All citations must follow APA 7th format. Use (Author, Year) in-text. Only add [VERIFY] if you cannot determine the year from research context."

---

## Formatted Structure

### Title Page
**Required Elements:**
-   Running head (optional for student papers, but common for professional papers)
-   Paper Title
-   Author(s) Name(s)
-   Author(s) Affiliation(s)
-   Course number and name (if student paper)
-   Instructor name (if student paper)
-   Due date (if student paper)

### Title
**Format:** Bold, Centered, 14pt. Placed on the title page and as a Level 1 heading before the Introduction.
**Max Length:** 100 characters (including spaces)
**Suggested:** A Hardware-Aware Hybrid Quantum-Classical Framework for Enhanced Binding Affinity Prediction in Drug Discovery

### Author Information
**Format:**
- Name(s): Full names, centered below the title.
- Affiliation(s): Department, University/Organization, City, State/Country, centered.
- Email(s): Corresponding author's email, typically as a footnote or after affiliations.
- ORCID: Optional, often included as a footnote for each author.

### Abstract
**Heading:** Bold, Centered (on its own page, following the title page)
**Length:** 250-300 words
**Structure:**
- Background (1-2 sentences): Computational methods are crucial for drug discovery, but accurately predicting molecular binding affinities, particularly for complex interactions, remains a significant challenge for classical approaches.
- Objective (1 sentence): This paper proposes a novel hardware-aware hybrid quantum-classical framework designed to integrate advanced quantum molecular simulation techniques into high-throughput drug discovery workflows.
- Methods (2-3 sentences): The framework systematically combines classical pre-screening for initial candidate selection, hardware-aware quantum simulation for precise interaction modeling, and classical post-processing for refinement, explicitly addressing current quantum hardware limitations.
- Results (2-3 sentences): A case study on a representative molecular system demonstrates that this hybrid approach significantly enhances the accuracy of binding affinity predictions compared to purely classical methods, particularly where quantum mechanical effects are predominant.
- Conclusions (1-2 sentences): This work offers a pragmatic pathway for leveraging quantum computing to improve early-stage drug discovery, providing more reliable predictions crucial for lead optimization and development.

**Keywords:** 3-6 keywords (e.g., Quantum Computing, Drug Discovery, Binding Affinity, Molecular Simulation, Hybrid Framework, High-Throughput Screening)

---

## 1. Introduction
**Section Number:** 1
**Heading:** **1. Introduction** (Bold, Centered, Title Case)
**Length:** 800-1200 words
**Subsections:**

### 1.1 Background and Motivation
**Format specifications:** Bold, Left-Aligned, Title Case. Discuss the importance of computational methods in drug discovery and the growing need for more accurate binding affinity predictions. Introduce the limitations of purely classical approaches.
**Content based on Logical Progression:** Classical drug discovery faces challenges with accuracy and efficiency for complex molecular interactions.

### 1.2 Problem Statement
**Format specifications:** Bold, Left-Aligned, Title Case. Clearly articulate the specific problem this research addresses: the gap in accurately predicting molecular binding affinities, especially for complex systems, and the current inability to effectively integrate promising quantum methods into existing workflows due to hardware constraints.

### 1.3 Research Question and Objectives
**Format specifications:** Bold, Left-Aligned, Title Case. State the primary research question.
**Research Question:** How can advanced quantum molecular simulation techniques be effectively integrated into classical high-throughput drug discovery workflows to enhance the accurate prediction of molecular binding affinities, considering current quantum hardware limitations?
**List format for objectives:**
1.  To review the current landscape of classical and quantum molecular simulation techniques in drug discovery and identify integration challenges.
2.  To propose a novel hardware-aware hybrid quantum-classical framework for molecular binding affinity prediction.
3.  To detail the methodology for implementing and validating the proposed framework, including considerations for current quantum hardware.
4.  To demonstrate the framework's effectiveness through a case study, comparing its performance against established classical methods.

### 1.4 Contributions
**Format specifications:** Bold, Left-Aligned, Title Case.
**Bullet format:**
-   Introduction of a novel, systematically designed hybrid quantum-classical framework for enhanced binding affinity prediction.
-   Development of a hardware-aware integration strategy that accounts for current quantum computing limitations.
-   Empirical validation through a case study demonstrating improved accuracy over classical methods for complex molecular systems.
-   Provision of a pragmatic roadmap for the adoption of quantum molecular simulations in early-stage drug discovery.

### 1.5 Paper Organization
**Format specifications:** Bold, Left-Aligned, Title Case.
[Standard paragraph describing the structure of the rest of the paper.]

---

## 2. Related Work and Background
**Section Number:** 2
**Heading:** **2. Related Work and Background** (Bold, Centered, Title Case)
**Length:** 1500-2500 words
**Organization:** Thematic subsections, integrating both classical and quantum approaches.
**Content based on Logical Progression:** Existing quantum molecular simulation methods show promise but lack practical integration into high-throughput workflows and often overlook hardware limitations.

### 2.1 Classical Approaches to Binding Affinity Prediction
**Format:** Bold, Left-Aligned, Title Case.
[Format: narrative discussing force fields, docking, MD simulations, etc. Include their strengths and limitations, especially concerning accuracy for complex interactions.]

### 2.2 Quantum Molecular Simulation Techniques
**Format:** Bold, Left-Aligned, Title Case.
[Format: narrative discussing ab initio methods, DFT, quantum chemical calculations. Focus on their theoretical accuracy and computational cost. Introduce emerging quantum algorithms for chemistry (e.g., VQE, QPE for molecular energies).]

### 2.3 Challenges in Integrating Quantum Methods into Drug Discovery
**Format:** Bold, Left-Aligned, Title Case.
[Format: narrative focusing on computational resource demands, current quantum hardware limitations (noise, qubit count, connectivity), and the gap in high-throughput applicability.]

**Table 1:** Summary of Relevant Computational Methods for Binding Affinity
| Method Category | Specific Method | Key Principle | Strengths | Limitations | Relevance to Hybrid Framework |
|-----------------|-----------------|---------------|-----------|--------------|-------------------------------|
| Classical       | Molecular Docking | Geometric fit | Fast, high-throughput | Accuracy issues, no dynamics | Pre-screening |
| Classical       | MD Simulations  | Newtonian mechanics | Dynamics, flexibility | High cost, force field dep. | Refinement, sampling |
| Quantum         | DFT             | Electron density | High accuracy for small systems | High cost, scaling | Reference data, specific interactions |
| Quantum         | VQE             | Variational principle | Near-term quantum algorithm | Hardware noise, qubit count | Core quantum component |
*Source: Adapted from [VERIFY] and [VERIFY].*

### 2.4 Summary and Gap Analysis
**Format:** Bold, Left-Aligned, Title Case.
[Synthesis paragraph highlighting the unaddressed gap: the lack of a practical, hardware-aware framework that bridges the accuracy of quantum simulations with the throughput needs of drug discovery.]

---

## 3. Proposed Hybrid Quantum-Classical Framework
**Section Number:** 3
**Heading:** **3. Proposed Hybrid Quantum-Classical Framework** (Bold, Centered, Title Case)
**Length:** 1000-1500 words
**Content based on Logical Progression:** Our proposed hybrid quantum-classical framework addresses these gaps by systematically combining classical pre-screening, hardware-aware quantum simulation, and classical post-processing.

### 3.1 Overall Framework Architecture
**Format:** Bold, Left-Aligned, Title Case.
[Format: paragraph + conceptual diagram illustrating the workflow.]

**Figure 1:** Conceptual Diagram of the Hybrid Quantum-Classical Drug Discovery Framework
[Placeholder for conceptual diagram showing the flow from classical pre-screening to quantum refinement and classical post-processing. Caption format: Figure 1. Conceptual Diagram of the Hybrid Quantum-Classical Drug Discovery Framework. This diagram illustrates the sequential stages of the proposed framework, integrating classical and quantum computational steps.]

### 3.2 Classical Pre-screening and Candidate Selection
**Format:** Bold, Left-Aligned, Title Case.
[Format: narrative + specification table.]
Details on using classical docking and molecular dynamics to filter and prioritize promising drug candidates for quantum analysis, focusing on criteria for selection.

**Table 2:** Criteria for Candidate Selection for Quantum Analysis
| Attribute | Description | Threshold/Method |
|-----------|-------------|------------------|
| Binding Score | Docking score from [Software] | Top 10% |
| Ligand Complexity | Number of rotatable bonds, heavy atoms | > 10 heavy atoms |
| Active Site Interactions | Key hydrogen bonds, hydrophobic contacts | Presence of 3+ key interactions |
*Source: Developed for this study.*

### 3.3 Hardware-Aware Quantum Simulation Module
**Format:** Bold, Left-Aligned, Title Case.
[Format: detailed narrative focusing on specific quantum algorithms, hardware mapping, error mitigation strategies.]

#### 3.3.1. Quantum Algorithm Selection and Adaptation.
**Format:** Bold, Indented, Sentence case, ending with a period.
[Discussion of VQE or similar variational algorithms, their suitability for near-term devices, and adaptations for molecular binding energy calculations.]

#### 3.3.2. Quantum Hardware Considerations and Error Mitigation.
**Format:** Bold, Indented, Sentence case, ending with a period.
[Details on qubit mapping, gate decomposition, noise resilience, and specific error mitigation techniques employed (e.g., zero-noise extrapolation, measurement error mitigation).]

### 3.4 Classical Post-processing and Refinement
**Format:** Bold, Left-Aligned, Title Case.
[Format: narrative + numbered steps.]
Discussion of how quantum simulation results are integrated back into classical models for further refinement, e.g., re-scoring, enhanced sampling, or re-docking with quantum-derived parameters.
1.  Step 1: [Description of how quantum-derived energies are used to refine classical force field parameters or re-rank candidates.]
2.  Step 2: [Description of any subsequent classical simulations (e.g., MM/GBSA, FEP) that leverage the quantum insights.]

---

## 4. Case Study: Demonstration and Results
**Section Number:** 4
**Heading:** **4. Case Study: Demonstration and Results** (Bold, Centered, Title Case)
**Length:** 1500-2000 words
**Content based on Logical Progression:** A case study demonstrates how this framework enhances binding affinity predictions for a representative molecular system, outperforming classical methods in accuracy where quantum advantage is relevant.

### 4.1 Molecular System and Experimental Setup
**Format:** Bold, Left-Aligned, Title Case.
[Format: narrative + specification table.]
Description of the chosen protein-ligand system (e.g., a specific enzyme-inhibitor pair known for challenging classical predictions), details of the classical and quantum computational environments.

**Table 3:** Molecular System and Computational Parameters
| Parameter | Description |
|-----------|-------------|
| Protein   | [Protein name, PDB ID] |
| Ligand    | [Ligand name, SMILES] |
| Classical Software | [Docking software, MD suite] |
| Quantum Simulator/Hardware | [Simulator name/Quantum computer] |
| Qubits Used | [Number] |
| Quantum Algorithm | [VQE, etc.] |
*Source: Data generated for this study.*

### 4.2 Classical Baseline Predictions
**Format:** Bold, Left-Aligned, Title Case.
[Format: text + table/figure.]
Present results from purely classical methods (e.g., docking scores, MM/GBSA energies) and compare them to experimental binding affinities.

**Figure 2:** Comparison of Classical Binding Affinity Predictions vs. Experimental Data
[Placeholder for a scatter plot or bar chart. Caption format: Figure 2. Comparison of Classical Binding Affinity Predictions with Experimental Data for [Molecular System]. This figure illustrates the correlation and deviation of classical computational methods from known experimental binding affinities.]

### 4.3 Hybrid Framework Predictions
**Format:** Bold, Left-Aligned, Title Case.
[Format: subsection per finding + visualization.]
Present the results obtained using the proposed hybrid framework.

#### 4.3.1. Quantum Energy Contribution to Binding.
**Format:** Bold, Indented, Sentence case, ending with a period.
[Discussion of how quantum simulations refined specific interaction energies.]

#### 4.3.2. Enhanced Binding Affinity Accuracy.
**Format:** Bold, Indented, Sentence case, ending with a period.
[Present the final binding affinity predictions from the hybrid framework, comparing them directly to classical methods and experimental data.]

**Figure 3:** Improved Binding Affinity Prediction Accuracy with Hybrid Framework
[Placeholder for a plot showing improved correlation or reduced error compared to Figure 2. Caption format: Figure 3. Improved Binding Affinity Prediction Accuracy with the Hybrid Quantum-Classical Framework. This visualization demonstrates the enhanced agreement between predicted and experimental binding affinities when utilizing the proposed hybrid approach.]

### 4.4 Performance and Resource Analysis
**Format:** Bold, Left-Aligned, Title Case.
[Format: text + supplementary figures.]
Discuss the computational cost, runtime, and resource utilization of the quantum module within the hybrid framework, acknowledging hardware limitations.

---

## 5. Discussion
**Section Number:** 5
**Heading:** **5. Discussion** (Bold, Centered, Title Case)
**Length:** 1500-2000 words
**Content based on Logical Progression:** This integration advances the field by providing a pragmatic pathway for quantum computing to contribute to early-stage drug discovery, offering more reliable predictions for lead optimization.

### 5.1 Interpretation of Findings
**Format:** Bold, Left-Aligned, Title Case.
[Format: narrative with citations.]
Discuss the significance of the improved accuracy in binding affinity prediction, emphasizing where the quantum component made the most impact.

### 5.2 Comparison with Prior Work
**Format:** Bold, Left-Aligned, Title Case.
[Format: comparative discussion.]
Relate the findings to existing literature on both classical and quantum drug discovery methods, highlighting how the hybrid framework addresses identified gaps.

### 5.3 Theoretical Implications
**Format:** Bold, Left-Aligned, Title Case.
[Format: paragraph.]
Discuss how this work contributes to the theoretical understanding of quantum advantage in chemical simulations and the development of hybrid algorithms.

### 5.4 Practical Implications
**Format:** Bold, Left-Aligned, Title Case.
[Format: bullet points or paragraphs.]
Discuss the real-world impact on drug discovery pipelines, potential for faster lead optimization, and identification of novel drug candidates.

### 5.5 Limitations and Future Work
**Format:** Bold, Left-Aligned, Title Case.
[Format: honest assessment.]
Acknowledge the limitations of the current study (e.g., specific molecular system, current quantum hardware constraints, scalability) and propose concrete directions for future research.

---

## 6. Conclusion
**Section Number:** 6
**Heading:** **6. Conclusion** (Bold, Centered, Title Case)
**Length:** 500-700 words

[No subsections - continuous narrative]

**Required elements:**
- Restate problem and approach: Reiterate the challenge in binding affinity prediction and how the hybrid framework addresses it.
- Summarize key findings: Briefly summarize the main results from the case study.
- Emphasize contributions: Highlight the innovative aspects and significance of the proposed framework.
- Suggest future directions: Briefly outline the most promising avenues for further research and development.

---

## Acknowledgments
**Heading:** **Acknowledgments** (Bold, Centered, Title Case)
[If applicable - funding, contributors, computational resources.]

---

## References
**Heading:** **References** (Bold, Centered, Title Case)
**Format:** APA 7th Edition
**Minimum:** 30-50 references for a theoretical paper with empirical demonstration.

**Categories:**
- Foundational works (pre-2019): [~20-30%]
- Recent works (2020-2024): [~70-80%]
- Including own prior work: [Optional, max 10%]

**Example APA 7th Reference Formats:**
-   **Journal Article:**
    Author, A. A., Author, B. B., & Author, C. C. (Year). Title of article. *Title of Periodical, volume*(issue), pages. https://doi.org/xxxx
-   **Book:**
    Author, A. A. (Year). *Title of work*. Publisher.
-   **Book Chapter:**
    Author, A. A. (Year). Title of chapter. In E. E. Editor & F. F. Editor (Eds.), *Title of work* (pp. pages). Publisher.
-   **Website:**
    Author, A. A. (Year, Month Day). *Title of work*. Site name. URL

---

## Appendices
**Heading:** **Appendix A: [Title of Appendix]** (Bold, Centered, Title Case)
[If applicable]
- Appendix A: Supplementary details on quantum circuit implementation and error mitigation parameters.
- Appendix B: Detailed classical simulation protocols and force field parameters.

---

## Journal-Specific Requirements

### Journal of Chemical Information and Modeling (ACS Publications)

**Mandatory sections:**
- [X] Data Availability Statement (typically required, specify where data can be found or if it's included in supplementary info)
- [X] Conflict of Interest Statement (required)
- [X] Author Contributions (if multiple authors, required)
- [X] Funding Statement (required, detail all funding sources)
- [X] Supporting Information (Appendices/Supplementary Materials)

**Formatting specifics:**
- Figures: High-resolution (min 300dpi for images, vector graphics preferred for line art), embedded within the text or placed at the end. Must be clearly labeled (e.g., Figure 1) with descriptive captions.
- Tables: Editable format (not images), numbered sequentially (e.g., Table 1) with clear titles above the table and footnotes below.
- Equations: Numbered sequentially, right-aligned (e.g., (1)). Use an equation editor.
- Chemical Structures: Use standard chemical drawing software (e.g., ChemDraw) and embed as high-resolution images.
- SI Units: Use International System of Units (SI) throughout.

**Submission checklist:**
- [X] Cover letter (addressed to the Editor-in-Chief, explaining significance)
- [X] Table of Contents Graphic (Graphical Abstract, required for ACS journals, concise visual summary)
- [X] Supporting Information (separate file for detailed methods, additional figures, raw data, etc.)
- [X] Authorship and Conflict of Interest Disclosure forms (may be required upon submission)
- [X] Peer Reviewers (suggest 3-5 potential reviewers)

---

## Length Targets by Section (approx. for 9,000 words)

| Section | Words | % of Total |
|---------|-------|------------|
| Abstract | 300 | 3% |
| Introduction | 1000 | 11% |
| Related Work | 2000 | 22% |
| Methodology | 1500 | 17% |
| Results | 1800 | 20% |
| Discussion | 1600 | 18% |
| Conclusion | 800 | 9% |
| **Total** | **9000** | **100%** |

---

## Quality Checklist

### Structure
- [X] All required sections present
- [X] Logical flow between sections
- [X] Appropriate section lengths

### Formatting
- [X] Consistent heading styles
- [X] Proper citation format (APA 7th)
- [X] Figures/tables numbered correctly
- [X] Captions complete and descriptive

### Content
- [X] Abstract summarizes whole paper
- [X] Introduction states clear RQ and thesis
- [X] Methods enable replication
- [X] Results presented objectively, addressing RQ
- [X] Discussion interprets findings, links to RQ and literature
- [X] Conclusion emphasizes contribution and future work

---

## Style Guide

### Academic Tone
- ✅ **Use:** "The results indicate...", "We observed...", "This suggests..."
- ❌ **Avoid:** "Obviously...", "Clearly...", "It's interesting that..."

### Tense Usage
- **Introduction:** Present tense (current state, established facts)
- **Literature Review:** Past tense (what others found), Present tense (current understanding/theories)
- **Methods:** Past tense (what you did)
- **Results:** Past tense (what you found)
- **Discussion:** Present tense (what it means, implications), Past tense (referring to your own results)

### Voice
- **Active vs Passive:** Prefer active for clarity, passive for objectivity. Aim for a balance.
- ✅ "We analyzed the data" (active, clear)
- ✅ "The data were analyzed" (passive, objective, common in methods)

---

## Next Steps

After formatting:
1. Review against journal guidelines (Journal of Chemical Information and Modeling)
2. Ensure all placeholders are noted (e.g., [VERIFY], [Placeholder for...])
3. Proceed to Compose phase with clear structure
4. Save to `outline_formatted.md`

```